Login / Signup
Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial.
Feng Wen
Tianhai Lin
Peng Zhang
Hao Zeng
Qiang Wei
Yali Shen
Published in:
BMJ open (2024)
Chinese Ethics Committee of Registering Clinical Trials (ChiCTR2200059970).
Keyphrases
</>
muscle invasive bladder cancer
clinical trial
early stage
public health
spinal cord injury
open label
radiation therapy
locally advanced
big data
squamous cell carcinoma
phase ii
machine learning
rectal cancer
placebo controlled
global health
double blind